MaRI is a developer of non-contact SAS treatment devices for sleeping disorders.
MaRI has raised $665K in total funding. The most recent round was Series B. The last funding was announced in February 2024.
MaRI's investors include Global Brain Corporation, SMBC Venture Capital, Kyoto University Innovation Capital, MedVenture Partners, Kyoto Capital Partners.
MaRI is headquartered in Kyoto, Japan.
MaRI is a developer of non-contact SAS treatment devices for sleeping disorders.
MaRI is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MaRI — Funding & Investors." VCBacked, February 21, 2024, https://www.vcbacked.co/company/mari. Accessed September 30, 2026.
VCBacked. (2024). MaRI — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/mari
{{cite web |title=MaRI — Funding & Investors |url=https://www.vcbacked.co/company/mari |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated